Early and Complete Response of Bone Metastases, Documented by FDG-PET/CT Scan, in a Patient With NSCLC

In this case report we describe the case of a patient with multiple bone metastases of NSCLC, adenocarcinoma with exon 21 point-mutation of EGFR, treated with gefitinib. After only 3 months, FDG-PET/CT scan showed a complete response of bone metastases and right hylar adenopathy. Implications for ne...

Descripción completa

Detalles Bibliográficos
Autores principales: Rossi, David, Giordani, Paolo, Alessandroni, Paolo, Catalano, Vincenzo, Casadei, Virginia, Baldelli, Anna Maria, Fedeli, Stefano Luzi, Graziano, Francesco, Fiorentini, Giammaria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2012
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5649835/
https://www.ncbi.nlm.nih.gov/pubmed/29147277
http://dx.doi.org/10.4021/wjon441w
Descripción
Sumario:In this case report we describe the case of a patient with multiple bone metastases of NSCLC, adenocarcinoma with exon 21 point-mutation of EGFR, treated with gefitinib. After only 3 months, FDG-PET/CT scan showed a complete response of bone metastases and right hylar adenopathy. Implications for need of early use of FDG-PET/CT scan after gefitinib treatment are discussed.

Ejemplares similares